The high expression of glycolytic enzyme alpha-enolase (ENO1), a key biomarker in tumor glycolytic metabolism, dramatically promoted cell growth and migration in A549 cells by activating the FAK/PI3K/AKT signaling pathway (Fu et al., 2015). Here, AKT1 is linked to neoplasm.